it releases a large volume of gas when heated. Generally, azodicarbonamide is a fine yellow powder but it may also have an orange crystalline appearance.
Its acute oral or inhalation2 toxicity is low in animals and no chronic toxicity has been reported. 3 It is considered as a non-toxic product for man," although it has a low potential for causing allergic sensitisation.
It is allowed for use in some European countries and since 1962 in the United States to mature and bleach cereal flours. In France it is only allowed as a component of food packaging material.
We here report four cases of lung disease associated with exposure to azodicarbonamide in the plastic industry.
Case 1
A 50 year old man, a former smoker and a chronic alcoholic, first experienced breathlessness when at work in 1975 and in 1978 presented with an eczematous dermatitis of the face.
Since the end of 1972 he had worked at a small plastic processing factory and been employed as a pigment grinder since the beginning of 1982. This job consists of preparing pigments and blowing agents in mixing and grinding machines.
He was seen for the first time at the beginning of 1983, with complaints ofacute episodes ofshortness of breath for three months. His dyspnoea gradually developed five or six hours after he had started work and often appeared in the middle of the night. The Accepted 18 January 1988 symptoms became worse at the end of the week and disappeared during the holidays. They disappeared completely in July 1983, when he was transferred because of his symptoms to the dispatching store.
As On the basis of their strong relation to work both with regard to time and location, we are confident that the four cases of asthma described were due to exposures at work. We cannot totally exclude the possibility that substances other than azodicarbonamide were implicated in the cases described; however, the inhalation challenges performed with the azodicarbonamide used by two workers and the clear association with the use of azodicarbonamide in the other two subjects strongly point to this (or possibly a contaminant) as the causative agent.
The causative agent remained unknown until we saw the second patient, who worked on the samejob as the first and who associated his complaints with the use of azodicarbonamide. This led us to attempt specific inhalation tests which proved to be positive. In the first case the test, though performed a year after withdrawal of the exposure, was positive, showing a late reaction occurring at home (in France it is current practice not to admit to hospital subjects undergoing inhalation challenge testing). Patients 3 and 4 were not tested because we thought the relation between exposure to azodicarbonamide and asthma was sufficiently established on clinical grounds.
In all cases the attacks of asthma disappeared after exclusion of the agent or changes in working conditions. They have reappeared only after an accidental or controlled medical re-exposure.
Asthma and asthmatic dyspnoea resulting from inhalation of azodicarbonamide powder have been previously described. They were mentioned for the first time in the United States in 1971, after ten cases appeared in a grinding factory'; 28 cases were identified in the United Kingdom in 1980 on the basis of a questionnaire study in the plastics industry,8 and two cases were described in Canada.9 In France azodicarbonamide has been considered as a possible respiratory allergen in the rubber industry.'"
The characteristics of our four cases of asthma are similar to those described elsewhere. After the first contact and a short period with no signs, the attacks appear suddenly, generally within six months of exposure,79 and in 75% of the cases before the end of the first year.8 The attacks happen with delay at the end of the day's work (more than half ofthem)8 or late in the night.'9 The occurrence of symptoms in case 4 on his first industrial exposure to this agent suggests that he had previously been exposed-for instance, as a baker even though the use of azodicarbonamide is not allowed as a food additive in France, or that other substances may cross react with azodicarbonamide.
Our patients have also noticed that their attacks of asthma occur both sooner and last longer as exposure persists for prolonged periods. 8 We have not been able to assess the prevalence of respiratory complaints in the firms involved, but estimates have varied between 18-5% (151 workers),8 164-47-3% (110 workers)," and 90% (11 workers)7 of those exposed. Not all these subjects, however, had asthma.
Only two patients have had a specific inhalation test with results similar to the second case.9
Two of our patients (cases 1 and 4) had had occupational asthma previously, though no increased incidence of azodicarbonamide induced asthma has been reported among atopic people.8
Three of our patients (1, 2, and 4) had had eczematous dermatitis, two when working in a bakery. Two cases of allergic contact dermatitis to azodicarbonamide have been reported, one in Italy'2 (a man working in an industrial bakery had eczema ofthe face and arms) and the other in the United Kingdom'3 (a worker in a plastic transforming factory had eczema of the body but not on face or arms). The skin tests have, in both cases, shown a delayed hypersensitivity to azodicarbonamide. The insolubility of azodicarbonamide in the usual solvents, however, renders testing difficult and is thus rarely performed.
